MedTrace Logo

Behavioral Insomnia Therapy For Those With Insomnia and Depression

NCT00620789 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 477

Last updated 2013-05-31

No results posted yet for this study

Summary

This study is a randomized clinical trial to test the efficacy of Cognitive-Behavioral Insomnia Therapy when used in isolation or in combination with antidepressant medication (escitalopram) among patients with Major depressive disorder and insomnia.

Conditions

Interventions

DRUG

Escitalopram + CBT-I

* Escitalopram, 10 mg daily for the duration of the study (6 months) * CBT-I, four biweekly sessions during eight week Treatment phase.

BEHAVIORAL

CBT-I plus placebo antidepressant medication

* CBT-I, 4 biweekly sessions, eight week Treatment phase. * Placebo,daily for duration of study(6 months).

DRUG

Escitalopram

* Escitalopram, 10 mg daily for the duration of the study (6 months) * SH, four biweekly sessions during eight week Treatment phase

Sponsors & Collaborators

  • Toronto Metropolitan University

    lead OTHER

Principal Investigators

  • Colleen Carney, PhD · Licensed, North Carolina Psychology Board, Ontario Psychological Association, Association for Behavioral and Cognative Therapies, ABCT Insomnia and other Sleep Disorders Special Interest Group, Sleep Research Society, American Academy of Sleep Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00620789 on ClinicalTrials.gov